Alnylam Pharmaceuticals Inc
2024W13
Asset class
C4_Shares
Geographical zone
4_NATO
Asset type
SP500
Activity sector
Health_Care
ADAM score (9 to 20)
9
ESG score (0 to 20)
0.0
Market Cap. €bn
17.4
Quotation currency
USD
ISIN code
US02043Q1076
Link to investor paqeLink to finance siteAnalysis of weekly valuations of the share Alnylam Pharmaceuticals Inc. This asset is quoted in USD. The valuations are in EURO equivalent and cover the weeks 2004W23 to 2024W13. The income from this financial asset is not known because it does not exist or is not available on the Yahoo Finance site. The ESG rating for this asset is not known.
Growth stab. (0 to 20)
0.1
Sharpe ratio
0.70
LT return %
20.1
LT recurring inc. %
0.0
LT return vs index %
9.5
Price-to-book
0.0
PER (TTM)
0.0
Chowder 5A (div%+div slope%)
0.0
1y Target Est (CV€)
206.3
Price level (in % or 0 to 20)
0.0
Bollinger Ratio 20 w.
-1.20
% of 1y positive return
63.3
Max drop in one week %
53.5
LT volatility %
30.2
Aucune image à afficher pour cet actif financier